Alnylam Pharmaceuticals stockALNY
Alnylam Pharmaceuticals trades at $156.66, 67.3% below its 52-week high (Dec 3, 2025). The price is below its 50- and 200-day averages, a downtrend. −60.6% year to date, −63.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 18, 2027.
Ratings, candles, signals and the screener for ALNY — after you log in
Open the terminalFrequently asked questions about Alnylam Pharmaceuticals
What is the Alnylam Pharmaceuticals stock price?
At the close on Nov 5, 2026: $156.66 (−2.74% on the day). 52-week high: $479.79 on Dec 3, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Alnylam Pharmaceuticals report earnings?
The next quarterly report is on Feb 18, 2027. Last quarter, earnings per share changed +754% year over year, revenue +17%.
Does Alnylam Pharmaceuticals pay dividends?
No, Alnylam Pharmaceuticals does not pay dividends.
Where does Alnylam Pharmaceuticals trade and how to buy it?
Ticker ALNY, exchange Nasdaq, listed since 2004. You can buy it through a broker with access to US exchanges.
Should I buy Alnylam Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ALNY are in the terminal after you log in.